全文获取类型
收费全文 | 9230篇 |
免费 | 663篇 |
国内免费 | 33篇 |
专业分类
耳鼻咽喉 | 116篇 |
儿科学 | 232篇 |
妇产科学 | 257篇 |
基础医学 | 1352篇 |
口腔科学 | 157篇 |
临床医学 | 1082篇 |
内科学 | 1986篇 |
皮肤病学 | 226篇 |
神经病学 | 1002篇 |
特种医学 | 274篇 |
外科学 | 884篇 |
综合类 | 73篇 |
一般理论 | 1篇 |
预防医学 | 840篇 |
眼科学 | 136篇 |
药学 | 597篇 |
中国医学 | 43篇 |
肿瘤学 | 668篇 |
出版年
2024年 | 12篇 |
2023年 | 100篇 |
2022年 | 216篇 |
2021年 | 394篇 |
2020年 | 267篇 |
2019年 | 276篇 |
2018年 | 323篇 |
2017年 | 248篇 |
2016年 | 295篇 |
2015年 | 339篇 |
2014年 | 395篇 |
2013年 | 532篇 |
2012年 | 764篇 |
2011年 | 784篇 |
2010年 | 437篇 |
2009年 | 388篇 |
2008年 | 600篇 |
2007年 | 548篇 |
2006年 | 528篇 |
2005年 | 500篇 |
2004年 | 421篇 |
2003年 | 377篇 |
2002年 | 353篇 |
2001年 | 60篇 |
2000年 | 46篇 |
1999年 | 52篇 |
1998年 | 76篇 |
1997年 | 49篇 |
1996年 | 39篇 |
1995年 | 34篇 |
1994年 | 37篇 |
1993年 | 23篇 |
1992年 | 22篇 |
1991年 | 19篇 |
1990年 | 20篇 |
1989年 | 15篇 |
1988年 | 23篇 |
1987年 | 14篇 |
1985年 | 16篇 |
1984年 | 16篇 |
1983年 | 13篇 |
1982年 | 19篇 |
1980年 | 12篇 |
1978年 | 12篇 |
1975年 | 11篇 |
1972年 | 12篇 |
1949年 | 10篇 |
1939年 | 10篇 |
1937年 | 24篇 |
1936年 | 23篇 |
排序方式: 共有9926条查询结果,搜索用时 15 毫秒
61.
Arturo Blazquez-Navarro Chantip Dang-Heine Patrizia Wehler Toralf Roch Chris Bauer Sindy Neumann Rodrigo Blazquez-Navarro Andriy Kurchenko Kerstin Wolk Robert Sabat Timm H. Westhoff Sven Olek Oliver Thomusch Harald Seitz Petra Reinke Christian Hugo Birgit Sawitzki Michal Or-Guil Nina Babel 《Transplant international》2021,34(9):1680-1688
Epstein–Barr virus (EBV) reactivation is a very common and potentially lethal complication of renal transplantation. However, its risk factors and effects on transplant outcome are not well known. Here, we have analysed a large, multi-centre cohort (N = 512) in which 18.4% of the patients experienced EBV reactivation during the first post-transplant year. The patients were characterized pre-transplant and two weeks post-transplant by a multi-level biomarker panel. EBV reactivation was episodic for most patients, only 12 patients showed prolonged viraemia for over four months. Pre-transplant EBV shedding and male sex were associated with significantly increased incidence of post-transplant EBV reactivation. Importantly, we also identified a significant association of post-transplant EBV with acute rejection and with decreased haemoglobin levels. No further severe complications associated with EBV, either episodic or chronic, could be detected. Our data suggest that despite relatively frequent EBV reactivation, it had no association with serious complications during the first post-transplantation year. EBV shedding prior to transplantation could be employed as biomarkers for personalized immunosuppressive therapy. In summary, our results support the employed immunosuppressive regimes as relatively safe with regard to EBV. However, long-term studies are paramount to support these conclusions. 相似文献
62.
Gordon Nicole T. Alberty-Oller Jaime J. Fei Kezhen Greco Giampaolo Gallagher Emily J. LeRoith Derek Feldman Sheldon M. Killilea Bridgid Boolbol Susan K. Choi Lydia Friedman Neil Pilewskie Melissa Port Elisa Tiersten Amy Bickell Nina A. 《Annals of surgical oncology》2021,28(11):5941-5947
Annals of Surgical Oncology - Black women with breast cancer have a worse overall survival compared with White women; however, no difference in Oncotype DX? (ODX) recurrence scores has been... 相似文献
63.
Stefan Schwarz Nina Rahimi Daria Kifjak Moritz Muckenhuber Martin Watzenböck Alberto Benazzo Peter Jaksch Sylvia Knapp Walter Klepetko Konrad Hoetzenecker the Vienna Lung Transplant Group 《American journal of transplantation》2021,21(6):2132-2144
Objectifying donor lung quality is difficult and currently there is no consensus. Several donor scoring systems have been proposed in recent years. They all lack large-scale external validation and widespread acceptance. A retrospective evaluation of 2201 donor lungs offered to the lung transplant program at the Medical University of Vienna between January 2010 and June 2018 was performed. Five different lung donor scores were calculated for each offer (Oto, ET, MALT, UMN-DLQI, and ODSS). Prediction of organ utilization, 1-year graft survival, and long-term outcome were analyzed for each score. 1049 organs were rejected at the initial offer (group I), 209 lungs declined after procurement (group II), and 841 lungs accepted and transplanted (group III). The Oto score was superior in predicting acceptance of the initial offer (AUC: 0.795; CI: 0.776–0.815) and actual donor utilization (AUC: 0.660; CI: 0.618–0.701). Prediction of 1-year graft survival was best using the MALT score, Oto score, and UMN-DLQI. Stratification of early outcome by MALT was significant for length of mechanical ventilation (LMV), PGD3 rates, ICU stay and hospital stay, and in-hospital-mortality, respectively. To the best of our knowledge, this study is the largest validation analysis comparing currently available donor scores. The Oto score was superior in predicting organ utilization, and MALT score and UMN-DLQI for predicting outcome after lung transplantation. 相似文献
64.
Laura N. Walti Catrina Mugglin Daniel Sidler Matteo Mombelli Oriol Manuel Hans H. Hirsch Nina Khanna Nicolas Mueller Christoph Berger Katia Boggian Christian Garzoni Dionysios Neofytos Christian van Delden Cédric Hirzel Swiss Transplant Cohort Study 《American journal of transplantation》2021,21(7):2532-2542
Posttransplant lymphoproliferative disorder (PTLD) is a serious complication of solid organ transplantation (SOT). Most PTLD cases are associated with Epstein–Barr virus (EBV) infection. The role of antiviral prophylaxis or rituximab therapy for prevention of PTLD in SOT recipients is controversial. In a nationwide cohort, we assessed the incidence, presentation, and outcome of histologically proven PTLD. We included 4765 patients with a follow-up duration of 23 807 person-years (py). Fifty-seven PTLD cases were identified; 39 (68%) were EBV positive (EBV+ PTLD). Incidence rates for EBV+ PTLD at 1, 2, and 3 years posttransplant were 3.51, 2.24, and 1.75/1000 py and 0.44, 0.25, and 0.29/1000 py for EBV− PTLD. We did not find an effect of antiviral prophylaxis on early and late EBV+ PTLD occurrence (early EBV+ PTLD: SHR 0.535 [95% CI 0.199–1.436], p = .264; late EBV+ PTLD: SHR 2.213, [95% CI 0.751–6.521], p = .150). However, none of the patients (0/191) who received a rituximab-containing induction treatment experienced PTLD, but 57 of 4574 patients without rituximab induction developed PTLD. In an adjusted restricted mean survival time model, PTLD-free survival was significantly longer (0.104 years [95% CI 0.077–0.131]) in patients receiving rituximab as induction treatment. This study provides novel data on the association of rituximab induction and reduced risk for PTLD. 相似文献
65.
Huang Samantha Blissett Gabriella Pei Bing April Balac Nina Bogner Jessica Reilly Jo Marie 《Journal of community health》2022,47(1):127-135
Journal of Community Health - Tattoos of formerly gang-involved and incarcerated individuals can negatively impact their ability to reintegrate into society. Laser tattoo removal is essential to... 相似文献
66.
Wolf Rasmus Trap Ratcliffe Julie Chen Gang Jeppesen Pia 《Quality of life research》2021,30(6):1747-1756
Quality of Life Research - The Child Health Utility 9D (CHU9D) currently represents the only preference-based health-related quality-of-life instrument designed exclusively from its inception for... 相似文献
67.
68.
Seitz RJ Knorr U Azari NP Herzog H Freund HJ 《Restorative neurology and neuroscience》1999,14(1):25-33
Recovery of finger movements after hemiparetic stroke has been shown to involve sensorimotor brain areas in perilesional and remote locations. Hand use, however, critically depends on visual guidance in such patients with stroke lesions in the middle cerebral artery territory. Using regional cerebral blood flow measurements, we wished to identify interrelated brain areas that are engaged in relation to manual activity in seven patients after their first hemiparetic brain infarction. During the blind-folded performance of sequential finger movements, the patients differed significantly from healthy controls (n = 7) by the recruitment of a predominantly contralesional network involving visual cortical areas, prefrontal cortex, thalamus, hippocampus, and cerebellum. Greater expression of this cortical-subcortical network correlated with a more severe sensorimotor deficit in the acute stage after stroke reflecting its role for post-stroke recovery. Patients also differed from controls on a lesion-related pattern expressed during rest. A third differentiating pattern involved the ipsilesional supplementary motor area and the contralesional premotor cortex. Our results suggest that post-stroke recovery form impaired sensorimotor integration utilizes crossmodal plasticity of a visual network. 相似文献
69.
Statins and peripheral neuropathy 总被引:3,自引:0,他引:3
Jeppesen U Gaist D Smith T Sindrup SH 《European journal of clinical pharmacology》1999,54(11):835-838
Within the past 3 years seven cases of reversible peripheral neuropathy apparently caused by statins have been reported.
Here we report seven additional cases associated with long-term statin therapy, in which other causes of neuropathy were thoroughly
excluded. The neuropathy was in all cases axonal and with affection of both thick and thin nerve fibers. The symptoms of neuropathy
persisted during an observation period lasting from 10 weeks to 1 year in four cases after statin treatment had been withdrawn.
We suggest that long-term statin treatment may be associated with chronic peripheral neuropathy.
Received: 6 July 1998 / Accepted in revised form: 1 October 1998 相似文献
70.
Rebecca Troisi Nancy Potischman James M Roberts Gail Harger Nina Markovic Bernard Cole David Lykins Pentti Siiteri Robert N Hoover 《Cancer epidemiology, biomarkers & prevention》2003,12(5):452-456
Evidence suggests that adult cancer risk of hormonally related tumors may be influenced by the in utero environment, and most speculation on the biological mechanism has focused on the hormonal component. Epidemiological studies investigating the biological nature of pregnancy and maternal factors associated with offspring's cancer risk have relied on maternal hormone measurements. The degree to which maternal hormone levels represent the fetal environment, however, is not widely known. Pregnancy estrogen, androstenedione, testosterone, dehydroepiandrosterone (DHEA), and DHEA-sulfate concentrations were measured in maternal and mixed umbilical cord sera from 86 singleton pregnancies. Spearman correlations between maternal and cord hormone levels generally ranged between 0.2 and 0.3. The correlation was 0.26 for estriol, the estrogen of highest concentration in pregnancy, and 0.27 for estradiol, the most biologically active estrogen. The correlations between mother and offspring for the estrogens and DHEA appeared similar for males and females, whereas there was a suggestion that the maternal-umbilical cord correlations for other androgens varied in magnitude by fetal sex, and all correlations appeared higher in pregnancies lasting <38 weeks compared with longer gestational lengths, although these stratified findings may have been attributable to chance. These data show a moderate degree of correlation in hormone concentrations between the maternal and fetal circulation. Studies using maternal hormone concentrations as a proxy for the fetal environment should consider the misclassification resulting with the use of this marker. 相似文献